ASE · Analyst Forecast

NanoViricides, Inc. (NNVC) Stock Forecast & Price Target

$1.16 ASE: NNVC Market Cap $29.61M

Price as of Nov 17, 2026 (intraday, delayed) · Analyst estimates retrieved Nov 16, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering NanoViricides, Inc. (NNVC), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For NanoViricides, Inc., analysts forecast revenue rising from $26.39M in 2023 to $133.50M in 2029; the average estimate for 2029 earnings per share is $0.95; 1 analyst contribute to these figures. These are forecasts published by analysts, not results.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2023$26.39M$26.39M$26.39M1
2025$0$0$01
2026$3.00M$3.00M$3.00M1
2027$7.00M$7.00M$7.00M1
2028$76.50M$76.50M$76.50M1
2029$133.50M$133.50M$133.50M1

Earnings per share forecast

YearLowAverageHighAnalysts
2023−$0.43−$0.43−$0.431
2025−$0.73−$0.73−$0.731
2026−$0.41−$0.41−$0.411
2027−$0.46−$0.46−$0.461
2028$0.50$0.50$0.501
2029$0.95$0.95$0.951

NanoViricides, Inc. (NNVC) forecast — frequently asked questions

What are analysts forecasting for NanoViricides, Inc.'s earnings?

The average analyst estimate for NanoViricides, Inc. (NNVC) earnings per share in 2029 is 0.95, with individual estimates between 0.95 and 0.95.

How much revenue is NanoViricides, Inc. expected to make?

Analysts forecast NanoViricides, Inc. (NNVC) revenue of $133.50M in 2029, based on 1 published estimates.

How many analysts cover NNVC?

1 analyst contribute estimates for NanoViricides, Inc. (NNVC). Thin coverage makes an average less reliable.

Analyst forecasts for other Biotechnology stocks

VRTX forecastREGN forecastMRNA forecastRVMD forecastROIV forecastINSM forecastUTHR forecastINCY forecastALNY forecastASND forecastAll Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.